Preparation of 2'-thio-2'-deoxycytidine 2':3'-phosphorothioate

Area of Science:

• * Organic Chemistry
• * Medicinal Chemistry
• * Biochemistry

Background:

• * Ribonucleotide analogs are crucial in antiviral and anticancer drug development.
• * Understanding the structure-activity relationship of modified nucleosides is key to designing effective therapeutics.
• * Phosphorothioate modifications can alter nucleotide stability and biological activity.

Purpose of the Study:

• * To describe the synthesis of a novel ribonucleotide analog: 2 -thio-2 -deoxycytidine 2 :3 -O,S-phosphorothioate.
• * To investigate the structural and reactivity differences between this new thioanalog and its non-thio counterpart (2 :3 -CMP).

Main Methods:

• * Thiophosphorylation of 2,2 -anhydro 1-beta-D-arabinosylcytosine using dithiophosphate.
• * Intramolecular displacement reaction to form the target phosphorothioate.
• * Structural and reactivity analysis of the synthesized compound.

Main Results:

• * Successful synthesis of the novel 2 -thio-2 -deoxycytidine 2 :3 -O,S-phosphorothioate.
• * Predominant formation of the 3 -O-phosphorothioate isomer during the initial thiophosphorylation step.
• * The synthesized thioanalog demonstrated significantly different structural and reactivity profiles compared to 2 :3 -CMP.

Conclusions:

• * A new synthetic route to a unique ribonucleotide thioanalog was established.
• * The synthesized 2 -thio-2 -deoxycytidine 2 :3 -O,S-phosphorothioate represents a distinct chemical entity with potential for further biological investigation.
• * The observed differences in structure and reactivity highlight the impact of phosphorothioate modification on nucleoside chemistry.